News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
3,379 Results
Type
Article (29)
Press Release (3350)
Section
Business (1335)
Career Advice (2)
Deals (180)
Drug Development (631)
FDA (95)
Job Trends (268)
News (2105)
Policy (116)
Tag
Academia (3)
Allergies (2)
Alliances (44)
Alzheimer's disease (31)
Antibody-drug conjugate (ADC) (7)
Approvals (120)
Artificial intelligence (2)
Autoimmune disease (2)
Best Places to Work (297)
Breast cancer (15)
Cancer (124)
Cardiovascular disease (11)
Career advice (1)
Cell therapy (1)
Cervical cancer (1)
Clinical research (714)
Collaboration (7)
Compensation (4)
COVID-19 (4)
C-suite (1)
Data (170)
Depression (1)
Diabetes (1)
Diagnostics (22)
Drug discovery (2)
Drug pricing (1)
Duchenne muscular dystrophy (1)
Earnings (1559)
Events (361)
FDA (173)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (6)
Generative AI (1)
Gene therapy (4)
GLP-1 (9)
Government (9)
Guidances (29)
Healthcare (86)
IgA nephropathy (3)
Infectious disease (5)
Inflammatory bowel disease (2)
IPO (162)
IRA (1)
Job creations (1)
Job search strategy (1)
Kidney cancer (2)
Layoffs (2)
Legal (1)
Lung cancer (41)
Lymphoma (16)
Manufacturing (3)
MASH (5)
Medical device (57)
Medtech (57)
Mergers & acquisitions (27)
Metabolic disorders (8)
Multiple sclerosis (9)
NASH (1)
Neurodegenerative disease (1)
Neuroscience (51)
NextGen: Class of 2026 (9)
Non-profit (4)
Obesity (1)
Opinion (1)
Ovarian cancer (4)
Pancreatic cancer (2)
Parkinson's disease (3)
Patents (1)
Patient recruitment (1)
Peanut (1)
People (9)
Phase 1 (108)
Phase 2 (216)
Phase 3 (428)
Pipeline (163)
Policy (1)
Postmarket research (27)
Preclinical (13)
Prostate cancer (4)
Radiopharmaceuticals (6)
Rare diseases (12)
Regulatory (168)
Reports (2)
Research institute (6)
Resumes & cover letters (1)
Rett syndrome (2)
RSV (1)
Schizophrenia (4)
Sponsored (1)
Startups (3)
Vaccines (6)
Weight loss (1)
Date
Today (2)
Last 7 days (9)
Last 30 days (27)
Last 365 days (418)
2026 (38)
2025 (424)
2024 (419)
2023 (423)
2022 (418)
2021 (481)
2020 (310)
2019 (202)
2018 (150)
2017 (116)
2016 (39)
2015 (73)
2014 (43)
2013 (25)
2012 (28)
2011 (23)
2010 (22)
Location
Asia (368)
Australia (14)
California (112)
Canada (28)
China (18)
Connecticut (5)
Delaware (20)
Europe (677)
Florida (13)
Georgia (2)
Illinois (11)
Indiana (21)
Japan (27)
Kansas (1)
Maryland (20)
Massachusetts (80)
Minnesota (10)
New Jersey (90)
New York (45)
North Carolina (14)
Northern California (77)
Ohio (4)
Pennsylvania (36)
South America (5)
Southern California (30)
Texas (17)
United States (507)
Utah (8)
Virginia (1)
Washington State (6)
3,379 Results for "%E2%80%9D%20target=".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sensorion Announces €60 Million Financing With a €20M Strategic Investment from Sanofi and Support from Global Healthcare Specialists To Advance Genetic Medicine Pipeline
January 28, 2026
·
15 min read
Press Releases
AstraZeneca results: FY and Q4 2025
February 10, 2026
·
12 min read
Press Releases
FDA approves RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) as the only EGFR-targeted therapy that can be administered once a month
February 17, 2026
·
32 min read
Press Releases
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong 2025 results with 7% sales growth
January 29, 2026
·
23 min read
Press Releases
GSK’s AREXVY Associated With Reductions in Certain RSV-Related Risks Including Heart Attack, Stroke and Severe Flare-Ups of COPD and Asthma, Real World Study Shows
February 18, 2026
·
15 min read
Press Releases
QIAGEN Exceeds Q4 2025 Outlook Driven by Growth Pillars
February 5, 2026
·
8 min read
Press Releases
Kisqali® Receives Positive Draft Recommendation From Canada’s Drug Agency For All Eligible Early Breast Cancer Patients at High Risk of Recurrence
February 8, 2026
·
9 min read
Press Releases
Pfizer’s BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer
February 17, 2026
·
18 min read
Press Releases
AB Science receives Japanese patent protection for the use of masitinib in progressive forms of multiple sclerosis (MS) until 2041
January 22, 2026
·
10 min read
Press Releases
RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) plus immunotherapy shows strong clinical benefit with 56 percent overall response rate in first-line recurrent or metastatic head and neck cancer
February 19, 2026
·
29 min read
1 of 338
Next
